Haikou Mingheng Biotechnology
Tirzepatide
Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Haikou Mingheng Biotechnology between 18 Sep 2025 and 15 Jan 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Haikou Mingheng Biotechnology
Tirzepatide
Tested 4 Samples
Last test 15 Jan 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Haikou Mingheng Biotechnology
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
15 Jan 2026
First
18 Sep 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 15 Jan 2026 | View | 10mg | 6.54mg | -34.6% | 98.46% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 4 Nov 2025 | View | 40mg | 46.13mg | +15.3% | 99.90% | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 6 Oct 2025 | View | 40mg | 46.4mg | +16.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 18 Sep 2025 | View | 30mg | 32.1mg | +7.0% | 99.95% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |